Responsible and forward-looking corporate governance – taking into account both the expected returns of our investors and the long-term development of the Group is a key concern for our Group.
Bentley Group’s governance bodies comprise the Management Board and the controlling non-executive Board of Directors.
(SWE) Kallelse_till_arsstamma_2025.pdf
The Chairman of the Board is second generation and as dedicated to the long-term development of the company as the founder. The Board of Directors consists of three members deeply rooted in the med-tech industry
Board of Directors
Chairwoman
Years of experience in MedTech: 16 years
Biography:
• Co-CEO in LS MedCap, now taking over the baton as Chairwoman of the Board in Bentley
• MBA from London Business School
• MSc in Cellular Biology, Genetics and Pharmacology from the University of Tübingen
Board of Directors
Member of the Board
Years of experience in MedTech: 50 years
Gründer und Mitglied des Vorstands von Bentley Erfolgreiche Gründung, Wachstum und Ausgründung mehrerer Unternehmen, wie z.B:
Biography:
Founder and Board member of Bentley. Successfully founded, grew and exited several other ventures, such as:
• Joka Kathetertechnik GmbH (Intensive Care, sold to Gambro AB, 1993)
• Jomed AG (Interventional Cardiology, IPO on SWX, 2000)
• Jostra AG (Cardiac Surgery, sold to Getinge AB, 2003)
• Jolife AB (Resuscitation, sold to Physio- Control, Inc. 2011)
Board of Directors
Member of the Board
Years of experience in MedTech: 9 years
Biography:
• Board member of Bentley since December 2018
• Bachelor of Sales & Marketing from Sawi
• CFC en Gestionaire de commerce de détail from EPCN
Board of Directors
Member of the Board
Geboren: Deutschland
Ausbildung: BA Internationales Marketing, Executive MBA (Donau-Universität)
Biografie: +29 Jahre Erfahrung in leitenden Positionen bei verschiedenen MedTech-Unternehmen,
darunter Maquet Cardiopulmonary, Heine Optotechnik und Carl Zeiss Meditec
The Group is managed by an experienced management team consisting of the CEO, CFO and CTO featuring a convincing strategic and financial track record when developing Bentley from start-up into one of the leading players in its market.
Management Board
CEO
Geboren: Deutschland
Ausbildung: BA Internationales Marketing, Executive MBA (Donau-Universität)
Biografie: +29 Jahre Erfahrung in leitenden Positionen bei verschiedenen MedTech-Unternehmen,
darunter Maquet Cardiopulmonary, Heine Optotechnik und Carl Zeiss Meditec
Management Board
CFO
Geboren: UK
Ausbildung: BA Finanz- und Rechnungswesen (UK und Deutschland), MBA mit Auszeichnung (Manchester Business School)
Hintergrund: +20 Jahre Erfahrung in der Leitung der Finanzabteilung in einem internationalen Umfeld.
12 Jahre in internationalen börsennotierten Unternehmen
Management Board
CTO
Geboren: Deutschland
Ausbildung: MSc. in Chemie (Hochschule Reutlingen), Executive MBA (European School of Business)
Hintergrund: 14 Jahre Erfahrung in MedTech-Unternehmen, darunter Translumina
The company has an audit committee consisting of Christoffer Rosenblad (Chair), James Mitchell, Eurico Pacheco. The tasks of the audit committee are set out in its instructions, which are adopted by the board of directors annually. The audit committee shall supervise the company’s financial reporting and the efficiency of the company’s internal control and risk management with reference to the financial reporting, be updated with reference to the audit of the annual report and other financial reports and examine and supervise the impartiality and the independency of the auditor.
The company has a remuneration committee consisting of Annika Sunnanväder (Chair), James Mitchell and Eurico Pacheco. The tasks of the remuneration committee are set out in its instructions, which are adopted by the board of directors annually. Its main task is to assist the board of directors in remuneration matters and submit proposals to ensure that compensation programs are designed to encourage high performance, promote accountability, and assure that employee interests are aligned with the interests of Bentley’s shareholders.